Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Computed tomography (CT)-guided intervention with and without fluoroscopic control: what are the benefits for the patient and the doctor?
ISRCTN ISRCTN23480116
ClinicalTrials.gov identifier
Public title Computed tomography (CT)-guided intervention with and without fluoroscopic control: what are the benefits for the patient and the doctor?
Scientific title
Acronym N/A
Serial number at source N0050149623
Study hypothesis Does the introduction of fluoroscopy in computed tomography (CT)-guided intervention decrease procedure time and dose exposure and does it make the procedure technically easier and improve outcome?
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Computed tomography-guided interventions
Participants - inclusion criteria All adult in-patients and out-patients attending for CT guided biopsies and drainages
Participants - exclusion criteria 1. Acute emergency cases
2. Inability to give informed consent
3. Unconscious patients
Anticipated start date 28/05/2004
Anticipated end date 28/11/2004
Status of trial Completed
Patient information material
Target number of participants 50
Interventions All patients attending for CT-guided interventions (biopsies and drainages) are invited to take part. Patients randomised to have procedure in conventional manner with CT guidance (controls) or with additional fluoroscopy. Time taken to have procedure, effective dose to patient, operator and assistant, patient comfort and acceptability, number of passes/complications and degree of technical success measured.
Primary outcome measure(s) 1. Dose product to patient
2. Effective dose to patient
3. Effective dose to doctor and nurse/assistant
4. Hand dose to doctor
5. Screening time
All measured using electronic dose meters

6. Comfort and acceptability Questionnaire
7. BIOPSY - Number of passes, complications and diagnostic specimens
8. DRAINAGES - Number of passes, Complications and Technical success
Secondary outcome measure(s) No secondary outcome measures
Sources of funding 1. Bradford Teaching Hospitals NHS Foundation Trust (UK)
2. Own account funding (UK)
Trial website
Publications
Contact name Dr  Andy  Lowe
  Address Department of Clinical Radiology
Bradford Royal Infirmary
Duckworth Lane
  City/town Bradford
  Zip/Postcode BD9 6RJ
  Country United Kingdom
  Tel +44 (0)1274 364492
  Fax +44 (0)1274 364304
  Email andylowe@doctors.org.uk
Sponsor Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
  Address The Department of Health
Richmond House
79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Fax +44 (0)20 7307 2623
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.dh.gov.uk/Home/fs/en
Date applied 30/09/2005
Last edited 07/04/2010
Date ISRCTN assigned 30/09/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central